We are thrilled to welcome on board Beji George as atHeart Medical’s Senior Director for Global Field Operations and Therapy Development. He will lead the American and European efforts for physician engagement and patient enrollment, as part of our clinical trial program.
Cardiac medical device expertise
Beji is an all-round expert in cardiac medical devices. He joins us from Abbott Laboratories Cardiac Rhythm Management business, where he supported the launch of a groundbreaking leadless pacemaker.
His proven track record combines extensive experience at major corporations like Abbott, Boston Scientific and Medtronic and at growing start-up companies like EBR Systems. Overall, he worked for 25 years in sales and clinical management, field operations and therapy development in the USA and worldwide.
“We are delighted to have on board such a recognized driven leader for our field team,” said Laurent Grandidier, atHeart Medical CEO. “Beji has a remarkable ability to cultivate strong business relationships with partnering healthcare centers. This will support the ongoing dialogue with the clinical teams participating in the ASCENT ASD study at a pivotal time.”
The ASCENT ASD study
ASCENT ASD is a global multi-site research study approved by US FDA, French ANSM, Health Canada and Swissmedic. The study will enroll up to 250 patients in over 20 centers across two continents. To date, over 100 patients have been successfully implanted as part ASCENT ASD.
“I am excited to join atHeart Medical and to share our mission to innovate atrial septal defect closure with our clinical partners,” said Beji. “These collaborations are critical for innovations to meet rigorous standards and to ultimately provide real-world solutions for patients that need them.”
Beji graduated in Kinesiology from University of Houston, Houston, Texas. Besides holding a Radiologic Sciences license from the American Registry of Radiologic Technologies, he is a former professional touring drummer (!).
.